These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31694589)

  • 1. Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations.
    Zhang J; Wang Y; Weng H; Wang D; Han F; Huang Q; Deng T; Wang X; Jin Y
    BMC Cancer; 2019 Nov; 19(1):1054. PubMed ID: 31694589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
    Babjuk M; Burger M; Compérat EM; Gontero P; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Zigeuner R; Capoun O; Cohen D; Escrig JLD; Hernández V; Peyronnet B; Seisen T; Soukup V
    Eur Urol; 2019 Nov; 76(5):639-657. PubMed ID: 31443960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.
    Maisch P; Retz M; Gschwend JE; Koll F; Schmid SC
    Urol Int; 2021; 105(1-2):31-40. PubMed ID: 32829338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).
    Witjes JA; Palou J; Soloway M; Lamm D; Kamat AM; Brausi M; Persad R; Buckley R; Colombel M; Böhle A
    BJU Int; 2013 Oct; 112(6):742-50. PubMed ID: 23452187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.
    Hendricksen K; Aziz A; Bes P; Chun FK; Dobruch J; Kluth LA; Gontero P; Necchi A; Noon AP; van Rhijn BWG; Rink M; Roghmann F; Rouprêt M; Seiler R; Shariat SF; Qvick B; Babjuk M; Xylinas E;
    Eur Urol Focus; 2019 Jul; 5(4):681-688. PubMed ID: 29074050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).
    Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Dominguez Escrig JL; Gontero P; Liedberg F; Masson-Lecomte A; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Seisen T; Soukup V; Sylvester RJ
    Eur Urol; 2022 Jan; 81(1):75-94. PubMed ID: 34511303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition).
    Jin YH; Zeng XT; Liu TZ; Bai ZM; Dou ZL; Ding DG; Fan ZL; Han P; Huang YR; Huang X; Li M; Li XD; Li YN; Li XH; Liang CZ; Liu JM; Ma HS; Qi J; Shi JQ; Wang J; Wang DL; Wang ZP; Wang YY; Wang YB; Wei Q; Xia HB; Xing JC; Yan SY; Zhang XP; Zheng GY; Xing NZ; He DL; Wang XH;
    Mil Med Res; 2022 Aug; 9(1):44. PubMed ID: 35978389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review.
    Mori K; Miura N; Babjuk M; Karakiewicz PI; Mostafaei H; Laukhtina E; Quhal F; Motlagh RS; Pradere B; Kimura S; Egawa S; Shariat SF
    Urol Oncol; 2020 Oct; 38(10):774-782. PubMed ID: 32654948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Fujita N; Hatakeyama S; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2020 Oct; 38(10):795.e9-795.e17. PubMed ID: 32417111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of breast cancer-related lymphoedema: Quality of clinical practice guidelines and variations in recommendations.
    Li M; Liu B; Chen C; Liu H; He S; Sun W; Yan Q; Rao X; Jin Y; Tan L
    Int J Nurs Pract; 2024 Jun; 30(3):e13127. PubMed ID: 36543600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of paediatric neurogenic lower urinary tract dysfunction guidelines using the Appraisal of Guidelines and Research Evaluation (AGREE) II instrument.
    Yadav P; Alsabban A; de Los Reyes T; Varghese A; Ming JM; Milford K; Yang SS; Silangcruz JM; Dos Santos J; Bagli DJ; Rickard M; Lorenzo AJ; Church P; Chua ME
    BJU Int; 2023 May; 131(5):520-529. PubMed ID: 36161751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
    Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
    Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Ventilator-Associated Pneumonia: Quality Assessment of Clinical Practice Guidelines and Variations in Recommendations on Drug Therapy for Prevention and Treatment.
    Li HY; Wang HS; Wang YL; Wang J; Huo XC; Zhao Q
    Front Pharmacol; 2022; 13():903378. PubMed ID: 35668946
    [No Abstract]   [Full Text] [Related]  

  • 15. EAU, AUA and NICE Guidelines on Surgical and Minimally Invasive Treatment of Benign Prostate Hyperplasia: A Critical Appraisal of the Guidelines Using the AGREE-II Tool.
    Enikeev D; Misrai V; Rijo E; Sukhanov R; Chinenov D; Gazimiev M; Taratkin M; Azilgareeva C; Morozov A; Herrmann TRW; Glybochko P
    Urol Int; 2022; 106(1):1-10. PubMed ID: 34350885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.
    Matulay JT; Tabayoyong W; Duplisea JJ; Chang C; Daneshmand S; Gore JL; Holzbeierlein JM; Karsh LI; Kim SP; Konety BR; Li R; McKiernan JM; Messing EM; Steinberg GD; Williams SB; Kamat AM
    Urol Oncol; 2020 Oct; 38(10):796.e1-796.e6. PubMed ID: 32430255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Critical Appraisal of Urticaria Clinical Practice Guidelines: A Global Guidelines in Dermatology Mapping Project (GUIDEMAP).
    Yen H; Yen H; Huang CH; Huang IH; Hung WK; Su HJ; Tai CC; Haw WWY; Flohr C; Yiu ZZN; Chi CC
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3213-3220.e11. PubMed ID: 37451615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the content and quality of clinical practice guidelines for management of the neurogenic bladder following spinal cord injury.
    Bragge P; Guy S; Boulet M; Ghafoori E; Goodwin D; Wright B
    Spinal Cord; 2019 Jul; 57(7):540-549. PubMed ID: 30971756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline of guidelines: non-muscle-invasive bladder cancer.
    Woldu SL; Bagrodia A; Lotan Y
    BJU Int; 2017 Mar; 119(3):371-380. PubMed ID: 28058776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are clinical practice guidelines for low back pain interventions of high quality and updated? A systematic review using the AGREE II instrument.
    Castellini G; Iannicelli V; Briguglio M; Corbetta D; Sconfienza LM; Banfi G; Gianola S
    BMC Health Serv Res; 2020 Oct; 20(1):970. PubMed ID: 33092579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.